MetaCap

Cartesian Therapeutics Statistics

NASDAQ: RNACHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.14+0.25 (+4.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cartesian Therapeutics by the numbers

Cartesian Therapeutics has a market capitalization of $187.3 million based on 30.50M shares outstanding. With trailing EPS of $-4.78, Cartesian Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 19.2% below its 200-day average.

Average daily trading volume is 139.65K shares, or about $857,457 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RNAC valuation vs. peer median

RNAC compared with the median of 8 peer companies
MetricRNACPeer medianDifference
Market cap$187.29M$186.96M+0%
Avg. volume139.65K244.05K-43%

Peer median across 8 companies: ANTX, WHWK, ACIU, SLGL, ADCT, YARW, BIOA, NATR.

Valuation

Market cap
$187.29M
Price / sales (latest FY)
66.96
EPS (TTM)
$-4.78

Price and trading

Previous close
5.89
Open
5.89
Day range
5.89 – 6.32
52-week range
5.60 – 11.00
52-week change
-15.19%
Beta
—
Volume
279.31K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
187.29M
Forward Pe
-4.83
Eps
-4.78
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
11.00
Week52 Low
5.60
Avg Volume
139.65K
Shares Outstanding
30.50M
Ma50
6.88
Ma200
7.60
Earnings Date
Nov 5, 2026
Pct From52w High
-44.18%
Pct From52w Low
9.64%

Related